Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Teh Seng Pharmaceutical Mfg Co Buyback Yield % Chart
Teh Seng Pharmaceutical Mfg Co Annual Data
Trend
Dec23
Dec24
Dec25
Buyback Yield %
0.00
0.00
0.00
Teh Seng Pharmaceutical Mfg Co Semi-Annual Data
Dec23
Jun24
Dec24
Jun25
Dec25
Buyback Yield %
0.00
0.00
0.00
0.00
0.00
ROCO:7860 vs ZTS: Buyback Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Teh Seng Pharmaceutical Mfg Co's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Teh Seng Pharmaceutical Mfg Co Buyback Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Teh Seng Pharmaceutical Mfg Co's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Teh Seng Pharmaceutical Mfg Co's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Teh Seng Pharmaceutical Mfg Co (ROCO:7860) has a Buyback Yield % of 0.00 as of Jul. 30, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Teh Seng Pharmaceutical Mfg Co and its competitors. According to the industry distribution chart, Teh Seng Pharmaceutical Mfg Co ranks #999999 out of 288 companies in the Drug Manufacturers industry.
Is Teh Seng Pharmaceutical Mfg Co's Buyback Yield % too high?
Teh Seng Pharmaceutical Mfg Co's current Buyback Yield % is 0.00. Based on the distribution chart, Teh Seng Pharmaceutical Mfg Co ranks #999999 out of 288 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Teh Seng Pharmaceutical Mfg Co has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Teh Seng Pharmaceutical Mfg Co's Buyback Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Teh Seng Pharmaceutical Mfg Co ranks #999999 out of 288 companies for Buyback Yield %. This places Teh Seng Pharmaceutical Mfg Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Drug Manufacturers company?
A good Buyback Yield % depends on the Drug Manufacturers industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Teh Seng Pharmaceutical Mfg Co and its competitors. Teh Seng Pharmaceutical Mfg Co's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Teh Seng Pharmaceutical Mfg Co stock overvalued right now?
Teh Seng Pharmaceutical Mfg Co (ROCO:7860) has a current Buyback Yield % of 0.00. The current Buyback Yield % is 0.00. Teh Seng Pharmaceutical Mfg Co's overall GF Score™ is 22/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Teh Seng Pharmaceutical Mfg Co (ROCO:7860), the current Buyback Yield % is 0.00 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Teh Seng Pharmaceutical Mfg Co Business Description
Teh Seng Pharmaceutical Mfg Co Ltd is engaged in the development and manufacturing of various pain relieving patches, cosmetic patches and biotechnology products. Its products include: Hydrogel Patches, Oil-Based Patches, Hot-Melt Patches, CMO & CRO for Transdermal Patch, Oral Film & Sublingual, Cosmetic Patches, Biotechnology Products and Daily Supplements.
22GF Score
Get the complete analysis for ROCO:7860
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7860 has been successfully added to your 
